Superstring Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Superstring Capital Management's MDGL Position: Q3 2026 in Review
Superstring Capital Management opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2026: 2,099 shares worth $1.06M. The stake represents 0.53% of the portfolio and ranks #29 among its holdings. This is a return to the name: Superstring Capital Management previously reported a position in MDGL as recently as Q1 2025.
Superstring Capital Management first reported a position in MDGL in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.26M in Q1 2025. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Superstring Capital Management held 2,099 shares of Madrigal Pharmaceuticals worth $1.06M as of Q3 2026.
- Madrigal Pharmaceuticals was a new Superstring Capital Management position in Q3 2026.
- Madrigal Pharmaceuticals made up 0.53% of Superstring Capital Management's portfolio in Q3 2026, its #29 holding.
- Superstring Capital Management first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
- Superstring Capital Management's Madrigal Pharmaceuticals position peaked at $1.26M in Q1 2025.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Superstring Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.